These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2654068)

  • 21. The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment.
    Topcu Y; Hiz Kurul S; Bayram E; Sozmen K; Yis U
    Acta Paediatr; 2014 Nov; 103(11):e484-9. PubMed ID: 25048365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flunarizine in migraine prophylaxis: an Indian trial.
    Thomas M; Behari M; Ahuja GK
    Headache; 1991 Oct; 31(9):613-5. PubMed ID: 1774179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
    Diener HC; Matias-Guiu J; Hartung E; Pfaffenrath V; Ludin HP; Nappi G; De Beukelaar F
    Cephalalgia; 2002 Apr; 22(3):209-21. PubMed ID: 12047461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flunarizine (Sibelium) in the prophylaxis of migraine. An open, long-term, multicenter trial.
    Martínez-Lage JM
    Cephalalgia; 1988; 8 Suppl 8():15-20. PubMed ID: 3052850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
    Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
    Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study.
    Olsson JE; Behring HC; Forssman B; Hedman C; Hedman G; Johansson F; Kinnman J; Pålhagen SE; Samuelsson M; Strandman E
    Acta Neurol Scand; 1984 Sep; 70(3):160-8. PubMed ID: 6391066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mentenopoulos G; Manafi T; Logothetis J; Bostantzopoulou S
    Cephalalgia; 1985 May; 5 Suppl 2():135-40. PubMed ID: 3893733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of migraine using flunarizine (results of a pilot study using Amalium)].
    Wessely P; Holzner F
    Wien Med Wochenschr; 1987 Jan; 137(1):21-6. PubMed ID: 3590812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine].
    Maissen CP; Ludin HP
    Schweiz Med Wochenschr; 1991 Oct; 121(43):1585-90. PubMed ID: 1947955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium channel blockers and prevention of migraine].
    Montastruc JL; Senard JM
    Pathol Biol (Paris); 1992 Apr; 40(4):381-8. PubMed ID: 1353873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flunarizine v. placebo in childhood migraine. A double-blind study.
    Sorge F; Marano E
    Cephalalgia; 1985 May; 5 Suppl 2():145-8. PubMed ID: 2861907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
    Johnson RH; Hornabrook RW; Lambie DG
    Acta Neurol Scand; 1986 May; 73(5):490-2. PubMed ID: 3524092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drugs for preventing migraine headaches in children.
    Victor S; Ryan SW
    Cochrane Database Syst Rev; 2003; (4):CD002761. PubMed ID: 14583952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo].
    Frenken CW; Nuijten ST
    Fortschr Med; 1984 Mar; 102(12):349-51. PubMed ID: 6370811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
    Wöber C; Wöber-Bingöl C; Koch G; Wessely P
    Cephalalgia; 1991 Dec; 11(6):251-6. PubMed ID: 1790569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study.
    Soyka D; Taneri Z; Oestreich W; Schmidt R
    Cephalalgia; 1988; 8 Suppl 8():35-40. PubMed ID: 3180201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine.
    Bussone G; Cerbo R; Martucci N; Micieli G; Zanferrari C; Grazzi L; Fabbrini G; Cavallini A; Granella F; Ambrosoli L; Mailland F; Poli A; Manzoni G
    Headache; 1999 Jun; 39(6):426-31. PubMed ID: 11279920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.